Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mind Medicine (MindMed) Inc.

5.77
+0.31005.68%
Post-market: 5.75-0.0200-0.35%19:48 EDT
Volume:1.17M
Turnover:6.66M
Market Cap:434.88M
PE:-3.74
High:5.84
Open:5.46
Low:5.45
Close:5.46
Loading ...

Company Profile

Company Name:
Mind Medicine (MindMed) Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
74
Office Location:
One World Trade Center,Suite 8500,New York,New York,United States
Zip Code:
10007
Fax:
- -
Introduction:
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.